| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,450 |
6,075 |
$340K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,309 |
1,945 |
$64K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,094 |
601 |
$40K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
229 |
226 |
$29K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
483 |
463 |
$23K |
| 90961 |
|
402 |
401 |
$17K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,015 |
711 |
$14K |
| 90674 |
|
418 |
261 |
$5K |
| 99222 |
Initial hospital care, per day, moderate complexity |
138 |
135 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
562 |
432 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
81 |
81 |
$4K |
| 99348 |
|
36 |
26 |
$3K |
| 99442 |
|
60 |
55 |
$2K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
116 |
111 |
$1K |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
71 |
71 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
397 |
350 |
$996.71 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
30 |
$899.72 |
| 90686 |
|
138 |
81 |
$718.35 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
270 |
253 |
$646.62 |
| 90962 |
|
13 |
13 |
$574.28 |
| 93000 |
|
53 |
53 |
$466.08 |
| 99223 |
Prolong inpt eval add15 m |
17 |
16 |
$450.62 |
| 99397 |
|
60 |
49 |
$441.91 |
| 99441 |
|
16 |
15 |
$348.66 |
| 99422 |
|
26 |
26 |
$326.67 |
| 36415 |
Collection of venous blood by venipuncture |
207 |
182 |
$258.94 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
17 |
$163.93 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
50 |
49 |
$38.54 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
13 |
$22.68 |
| J7050 |
Infusion, normal saline solution, 250 cc |
30 |
30 |
$2.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
35 |
33 |
$2.00 |